Wednesday, August 25, 2010

The binding of Toxoplasma gondii glycosylphosphatidylinositols to galectin-3 is required for their recognition by macrophages

J Biol Chem. 2010 Aug 20. [Epub ahead of print]

The binding of Toxoplasma gondii glycosylphosphatidylinositols to galectin-3 is required for their recognition by macrophages

Debierre-Grockiego F, Niehus S, Coddeville B, Elass E, Poirier F, Weingart R, Schmidt RR, Mazurier J, Guerardel Y, Schwarz RT.

UFR Sciences Pharmaceutiques, France;

Abstract
We showed that the production of tumor necrosis factor alpha by macrophages in response to Toxoplasma gondii glycosylphosphatidylinositols (GPIs) requires the expression of both Toll-Like Receptors TLR2 and TLR4, but not of their co-receptor CD14. Galectin-3 is a beta-galactoside-binding protein with immune-regulatory effects, which associates with TLR2. We demonstrate here by using the surface plasmon resonance method that the GPIs of T. gondii bind to human galectin-3 with strong affinity and in a dose-dependent manner. The use of a synthetic glycan and of the lipid moiety cleaved from the GPIs show that both parts are involved in the interaction with galectin-3. GPIs of T. gondii also bind to galectin-1 but with a lower affinity and only through the lipid moiety. At the cellular level, the production of tumor necrosis factor alpha induced by T. gondii GPIs in macrophages depends on the expression of galectin-3 but not of galectin-1. This study is the first identification of a galectin-3 ligand of T. gondii origin, and galectin-3 might be a co-receptor presenting the GPIs to the TLRs on macrophages.

PMID: 20729207 [PubMed - as supplied by publisher]

1 comment:

jsdaniels said...

Researchers Need Help from Toxoplasmosis diagnosed people! There are a number of research organizations attempting to better understand Toxoplasmosis as well as to develop better diagnostic test kits and treatments. On the diagnostics side, biotechnology companies like SeraCare Life Sciences and Biospecialties Corporation run a number of diagnostics research studies for people diagnosed with Toxoplasmosis, paying participants $400+ to donate blood samples which are used to develop Toxoplasmosis diagnostics test kits (see: http://www.idonateplasma.com.) On the research side, the Toxoplasmosis Research Institute is researching the proteomics, diagnostics, and epidemiology of Toxoplasmosis. On the clinical trial side, the National Institute of Health' sponsor a number of clinical trials.

There are many programs out there where you can GET PAID to help Toxoplasmosis Research, the most active of which are below:
http://www.idonateplasma.com

https://twitter.com/IDonatePlasma

http://www.myspace.com/seracare

http://www.linkedin.com/pub/i-donate-plasma-for-research/21/b09/726

http://www.facebook.com/pages/PAID-Plasma-Donations-for-Research/101071083280661?ref=ts


For daily up-to-date information of Toxoplasmosis research, check out these Twitter Lists:
https://twitter.com/IDonatePlasma/biotechnology-insights

https://twitter.com/iDonatePlasma/disease-research